These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 39142336

  • 1. Velagliflozin, a once-daily, liquid, oral SGLT2 inhibitor, is effective as a stand-alone therapy for feline diabetes mellitus: the SENSATION study.
    Behrend EN, Ward CR, Chukwu V, Cook AK, Kroh C, Lathan P, May J, Schermerhorn T, Scott-Moncrieff JC, Voth R.
    J Am Vet Med Assoc; 2024 Oct 01; 262(10):1343-1353. PubMed ID: 39142336
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Insulin glargine 300 U/ml for the treatment of feline diabetes mellitus.
    Linari G, Fleeman L, Gilor C, Giacomelli L, Fracassi F.
    J Feline Med Surg; 2022 Feb 01; 24(2):168-176. PubMed ID: 34009061
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
    Nelson RW, Henley K, Cole C, PZIR Clinical Study Group.
    J Vet Intern Med; 2009 Feb 01; 23(4):787-93. PubMed ID: 19566845
    [Abstract] [Full Text] [Related]

  • 6. Effects of the sodium-glucose cotransporter 2 (SGLT2) inhibitor velagliflozin, a new drug with therapeutic potential to treat diabetes in cats.
    Hoenig M, Clark M, Schaeffer DJ, Reiche D.
    J Vet Pharmacol Ther; 2018 Apr 01; 41(2):266-273. PubMed ID: 29139146
    [Abstract] [Full Text] [Related]

  • 7. Treatment of feline diabetes mellitus using an alpha-glucosidase inhibitor and a low-carbohydrate diet.
    Mazzaferro EM, Greco DS, Turner AS, Fettman MJ.
    J Feline Med Surg; 2003 Jun 01; 5(3):183-9. PubMed ID: 12765629
    [Abstract] [Full Text] [Related]

  • 8. Use of lispro insulin for treatment of diabetic ketoacidosis in cats.
    Malerba E, Mazzarino M, Del Baldo F, Corradini S, Carotenuto G, Giunti M, Fracassi F.
    J Feline Med Surg; 2019 Feb 01; 21(2):115-123. PubMed ID: 29513157
    [Abstract] [Full Text] [Related]

  • 9. SGLT2 inhibitor use in the management of feline diabetes mellitus.
    Cook AK, Behrend E.
    J Vet Pharmacol Ther; 2024 Jul 02. PubMed ID: 38954371
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pilot study assessing the use of cabergoline for the treatment of cats with hypersomatotropism and diabetes mellitus.
    Scudder CJ, Hazuchova K, Gostelow R, Church DB, Forcada Y, Fowkes RC, Niessen SJ.
    J Feline Med Surg; 2021 Feb 02; 23(2):131-137. PubMed ID: 32684121
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of protamine zinc insulin for treatment of diabetes mellitus in cats.
    Nelson RW, Lynn RC, Wagner-Mann CC, Michels GM.
    J Am Vet Med Assoc; 2001 Jan 01; 218(1):38-42. PubMed ID: 11149712
    [Abstract] [Full Text] [Related]

  • 13. Comparison of serum fructosamine and blood glycosylated hemoglobin concentrations for assessment of glycemic control in cats with diabetes mellitus.
    Elliott DA, Nelson RW, Reusch CE, Feldman EC, Neal LA.
    J Am Vet Med Assoc; 1999 Jun 15; 214(12):1794-8. PubMed ID: 10382020
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of bexagliflozin in cats with poorly regulated diabetes mellitus.
    Benedict SL, Mahony OM, McKee TS, Bergman PJ.
    Can J Vet Res; 2022 Jan 15; 86(1):52-58. PubMed ID: 34975223
    [Abstract] [Full Text] [Related]

  • 15. Pasireotide Long-Acting Release Treatment for Diabetic Cats with Underlying Hypersomatotropism.
    Gostelow R, Scudder C, Keyte S, Forcada Y, Fowkes RC, Schmid HA, Church DB, Niessen SJ.
    J Vet Intern Med; 2017 Mar 15; 31(2):355-364. PubMed ID: 28145031
    [Abstract] [Full Text] [Related]

  • 16. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study.
    Henry RR, Rosenstock J, Edelman S, Mudaliar S, Chalamandaris AG, Kasichayanula S, Bogle A, Iqbal N, List J, Griffen SC.
    Diabetes Care; 2015 Mar 15; 38(3):412-9. PubMed ID: 25271207
    [Abstract] [Full Text] [Related]

  • 17. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.
    Lee IH, Ahn DJ.
    Medicine (Baltimore); 2020 May 22; 99(21):e20228. PubMed ID: 32481295
    [Abstract] [Full Text] [Related]

  • 18. Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
    Michiels L, Reusch CE, Boari A, Petrie G, Mandigers P, Thollot IG, Rosenberg D, Mooney C, Bonfanti U, Font A, Sparkes A, Bewig K, Clercx C, Jensen AL, Horspool LJ.
    J Feline Med Surg; 2008 Oct 22; 10(5):439-51. PubMed ID: 18619886
    [Abstract] [Full Text] [Related]

  • 19. Effect of sodium-glucose cotransporter 2 inhibitor canagliflozin on interstitial glucose concentration in insulin-treated diabetic dogs.
    Box JR, Oyama MA, Mosenco AS, Hess RS.
    J Vet Intern Med; 2024 Oct 22; 38(3):1353-1358. PubMed ID: 38528660
    [Abstract] [Full Text] [Related]

  • 20. Management of feline diabetes mellitus.
    Rand JS, Martin GJ.
    Vet Clin North Am Small Anim Pract; 2001 Sep 22; 31(5):881-913. PubMed ID: 11570131
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.